Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”

المؤلفون المشاركون

López-Morales, Carlos A.
Miranda-Hernández, Mariana P.
Perdomo-Abúndez, Francisco C.
Revilla-Beltri, Jorge
Salazar-Flores, Rodolfo D.
Ramírez-Ibanez, Nancy D.
Molina-Pérez, Aaron
Pérez, Néstor O.
Medina-Rivero, Emilio
Flores-Ortiz, Luis F.

المصدر

Journal of Immunology Research

العدد

المجلد 2018، العدد 2018 (31 ديسمبر/كانون الأول 2018)، ص ص. 1-3، 3ص.

الناشر

Hindawi Publishing Corporation

تاريخ النشر

2018-02-21

دولة النشر

مصر

عدد الصفحات

3

التخصصات الرئيسية

الأحياء

الملخص EN

This communication responds to the Letter to the Editor [1], where noticeably Messrs.

Brian Hassett, Steven Vicik, and Brian Fitzpatrick from Pfizer Biotech contended that a particular glycan profile, presented in comparison to different profiles, does not correspond to the historical profile of the reference medicinal product of etanercept (Enbrel®), as it is exposed.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Miranda-Hernández, Mariana P.& López-Morales, Carlos A.& Perdomo-Abúndez, Francisco C.& Salazar-Flores, Rodolfo D.& Ramírez-Ibanez, Nancy D.& Pérez, Néstor O.…[et al.]. 2018. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research،Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1192699

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Miranda-Hernández, Mariana P.…[et al.]. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research No. 2018 (2018), pp.1-3.
https://search.emarefa.net/detail/BIM-1192699

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Miranda-Hernández, Mariana P.& López-Morales, Carlos A.& Perdomo-Abúndez, Francisco C.& Salazar-Flores, Rodolfo D.& Ramírez-Ibanez, Nancy D.& Pérez, Néstor O.…[et al.]. Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”. Journal of Immunology Research. 2018. Vol. 2018, no. 2018, pp.1-3.
https://search.emarefa.net/detail/BIM-1192699

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references

رقم السجل

BIM-1192699